In summary, studies supported by the NHLBI have markedly increased our knowledge of basic mechanisms of inflammation and fibrosis in the lung. A remarkable feature of these studies is the translation of this knowledge into studies of patients with inflammatory and fibrotic lung disease and the prospects of therapeutic advances on the horizon.